An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
InfuSystem Holdings, Inc. (NYSE American: INFU) will release its first quarter 2022 financial results on May 5, 2022, before market opening. A conference call will follow at 9:00 a.m. Eastern Time for discussion of the results. Interested parties can participate by calling (888) 567-1603 or via live webcast at the company's website. InfuSystem specializes in outpatient care for durable medical equipment, operating through its Integrated Therapy Services and Durable Medical Equipment Services platforms.
Positive
Leading national health care service provider with established market presence.
Diverse service offerings under two platforms: Integrated Therapy Services and Durable Medical Equipment Services.
Negative
None.
Investor Conference Call to be held 9:00 a.m. Eastern Time
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2022 financial results on Thursday, May 5, 2022, before the market opens.
The Company will also conduct a conference call for all interested parties on Thursday, May 5, 2022 at 9:00 a.m. Eastern Time to discuss its financial results.
To participate in this call, please dial (888) 567-1603 or (862) 298-0702, or listen via a live webcast, which is available in the Investors section of the Company’s website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ for the next 90 days or by calling (888) 539-4649 or (754) 333-7735, confirmation code 157114 through Thursday, May 12, 2022.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Integrated Therapy Services (“ITS”), providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The ITS segment is comprised of Oncology, Pain Management, Wound Therapy and Lymphedema businesses. The second platform, Durable Medical Equipment Services (“DME Services”), supports the ITS platform and leverages strong service orientation to win incremental business from its direct payer clients. The DME Services segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.
